Last year, Fulgent Genetics Inc generated 184.60M USD for its biggest-performing segment, Institutional. The United States made the largest contribution, accounting for 296.55M USD last year. For the latest quarter, Fulgent Genetics Inc reported the revenue of 44.23M USD for the period ending 2026-06-30, which came from the top-performing segment, Insurance. United States contributed the highest revenue, at 78.29M USD.

By Business

Revenue

Proportion

Annual

Annual

Quarterly

Institutional

Insurance

Patient

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

Institutional

184.60M(57.21%)

154.73M(54.59%)

134.19M(46.40%)

239.96M(38.77%)

435.69M(43.89%)

257.59M(61.08%)

31.28M(96.18%)

Insurance

130.25M(40.37%)

123.92M(43.72%)

151.95M(52.54%)

377.87M(61.05%)

555.76M(55.99%)

1.04M(0.25%)

705.00K(2.17%)

Patient

7.82M(2.42%)

4.81M(1.70%)

3.08M(1.06%)

1.13M(0.18%)

1.13M(0.11%)

163.08M(38.67%)

539.00K(1.66%)

By Region

Revenue

Proportion

Annual

Annual

Quarterly

United States

Foreign

Other Countries

Canada

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

United States

296.55M(91.91%)

259.13M(91.41%)

268.98M(93.00%)

603.15M(97.44%)

978.98M(98.63%)

415.33M(98.49%)

25.01M(76.90%)

Foreign

26.12M(8.09%)

24.34M(8.59%)

20.24M(7.00%)

15.82M(2.56%)

--(--)

Other Countries

--(--)

13.61M(1.37%)

4.65M(1.10%)

5.27M(16.20%)

Canada

--(--)

1.73M(0.41%)

2.25M(6.90%)